Takeda Pharmaceutical (TAK) Intangibles (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Intangibles of $21.3 billion for Q2 2026, down 10.05% year-over-year from $23.7 billion in Q2 2025, and down 2.42% quarter-over-quarter from $21.8 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Intangibles (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Intangibles history runs 10 years deep, the most recent figure standing at $21.3 billion for Q2 2026.
- In Q2 2026, Intangibles fell 10.05% year-over-year to $21.3 billion; the TTM figure through Jun 2026 stood at $21.3 billion (down 10.05% YoY), while the FY2026 annual figure was $22.7 billion, down 4.72% from the prior year.
- Intangibles for Q2 2026 stood at $21.3 billion, down from $21.8 billion in the prior quarter.
- The five-year high for Intangibles was $32.9 billion in Q2 2023, with the low at $21.3 billion in Q2 2026.
- The 5-year median for Intangibles is $27.2 billion (2022), against an average of $27.2 billion.
- The sharpest annual moves came in 2022 and 2023: Intangibles retreated 20.09% in 2022, then gained 3.98% in 2023.
- Takeda Pharmaceutical's Intangibles stood at $26.7 billion in 2022, then advanced by 3.98% to $27.7 billion in 2023, then decreased by 6.21% to $26.0 billion in 2024, then declined by 12.12% to $22.8 billion in 2025, then decreased by 6.87% to $21.3 billion in 2026.
- Business Quant data shows TAK's Intangibles at $21.3 billion in Q2 2026, $21.8 billion in Q1 2026, and $22.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.12 Bn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.28 Bn |
| Mar 31, 2026 | 21.80 Bn |
| Dec 31, 2025 | 22.84 Bn |
| Sep 30, 2025 | 22.39 Bn |
| Jun 30, 2025 | 23.65 Bn |
| Mar 31, 2025 | 23.80 Bn |
| Dec 31, 2024 | 26.00 Bn |
| Sep 30, 2024 | 25.28 Bn |
| Jun 30, 2024 | 28.05 Bn |
| Mar 31, 2024 | 28.84 Bn |
| Dec 31, 2023 | 27.72 Bn |
| Sep 30, 2023 | 30.48 Bn |
| Jun 30, 2023 | 32.94 Bn |
| Mar 31, 2023 | 32.28 Bn |
| Dec 31, 2022 | 26.66 Bn |
| Sep 30, 2022 | 30.32 Bn |
| Jun 30, 2022 | 32.05 Bn |
| Mar 31, 2022 | 32.86 Bn |
| Dec 31, 2021 | 33.36 Bn |
| Sep 30, 2021 | 34.37 Bn |